 |
|
|
| |
Long-Term Histological Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs
|
| |
| |
Reported by Jules Levin
DDW Chicago May 30-June 4 2009
YF Liaw1, TT Chang2, SS Wu3, ER Schiff4, KH Han5, CL Lai6, R Safadi7, SS Lee8, W Halota9, ZD Goodman10, H Zhang11, U Iloeje11, S Beebe11, B Kreter12, H Ishikawa13, Y Katano14, K Takaguchi15, M Omata16
1. Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan. 2. National Cheng Kung University Medical College, Tainan, Taiwan. 3. Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan. 4. University of Miami Hospital & Clinics, Miami, FL, USA. 5. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. 6. Department of Medicine, Queen Mary's Hospital, University of Hong Kong, Hong Kong, China. 7. Division of Medicine, Hadassah Medical Center, Jerusalem, Israel. 8. Liver Unit, University of Calgary, Calgary, AB, Canada. 9. Klinika Chorob Zakaznych AM, Bydgoszcz, Poland. 10. Armed Forces Institute of Pathology, Washington, WA, USA. 11. Research & Development, Bristol-Myers
Squibb Company, Wallingford, CT, USA. 12. Research & Development, Bristol-Myers Squibb Company, Princeton, NJ, USA. 13. Research & Development, Bristol-Myers KK, Tokyo, Japan. 14. Department of Gastroenterology, Graduate School of Medicine, Nagoya University, Aichi, Japan. 15.Department of Internal Medicine, Kagawa Prefectural Central Hospital, Kagawa, Japan. 16. Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo,
|
| |
|
|
|
|
|
